GlassScriptPhysician profile
Asher I Kupperman
NPI 1104141993
$1,399.18
in general payments reported to CMS, 2019-2025
12 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $155 · 2021: $151 · 2022: $69.52 · 2023: $113 · 2024: $251 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $354.77 | 2023-2025 | Pangea, Gamma, Variax |
| Depuy Synthes Sales INC. | $315.34 | 2019-2023 | Na, Va-Lcp |
| Endo USA, INC. | $172.40 | 2024-2025 | Xiaflex |
| Integra Lifesciences Corporation | $147.24 | 2019 | |
| Skeletal Dynamics INC | $117.65 | 2019 | |
| Fidia Pharma USA INC. | $95.44 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $73.63 | 2019-2024 | Xiaflex |
| Bioventus LLC | $42.41 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Djo, LLC | $34.26 | 2019-2025 | Donjoy |
| Smith+Nephew, INC. | $25.80 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Orthofix Medical, INC. | $20.24 | 2023 | Physio-Stim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$235,346.62 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asher Kupperman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.